JCR Pharmaceuticals Co., Ltd. provided earnings guidance for the fiscal year ending March 31, 2022. For the year, the company expects net sales to be JPY 49,000 million. Operating income to be JPY 18,700 million. Earnings per share to be JPY 107.68. Profit attributable to owners of the parent to be JPY 13,300 million.